Pacira Ireland Clinical Trials

Company details

Status: Public
HQ: Ranelagh, IE
Founded: 2007
Employees: 7
Programs: 100
Drugs: 32
Patents: 57

Official website ↗ All projects Drug pipeline Patents News & analysis

Recent trial activity

8 updates

Latest clinical program signals indexed for Pacira Ireland.

Trial registry

118 studies

NCT00003073
liposomal cytarabine

Phase 1 active small_molecule

Brain and Central Nervous System Tumors

CT.gov ↗
NCT00029523
Intrathecal (injected into the spinal fluid) DepoCyt

Approved completed small_molecule

Meningeal Neoplasms

CT.gov ↗
NCT00130351
formoterol

Phase 3 completed other

Asthma

CT.gov ↗
NCT00134979
Formoterol

Approved completed small_molecule

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT00485433
Bupivacaine HCl

Phase 3 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00485667
SKY0402

Phase 2 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00485693
Bupivacaine HCl

Phase 3 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00529126
SKY0402

Phase 2 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00728832
DepoDur (extended-release epidural morphine)

Phase 1 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00744848
Bupivacaine HCl

Phase 3 completed small_molecule

Hemorrhoids

CT.gov ↗
NCT00745290
Bupivacaine HCl

Phase 3 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT00806806
SKY0402

Phase 1 completed small_molecule

Postoperative Pain Management

CT.gov ↗
NCT00807209
Low Dose SKY0402

Phase 2 terminated small_molecule

Postoperative Pain

CT.gov ↗
NCT00812305
SKY0402 300mg in healthy patients

Phase 1 completed small_molecule

Pain

CT.gov ↗
NCT00813111
SKY0402

Phase 3 terminated small_molecule

Pain

CT.gov ↗
NCT00842062
MyoScience Tissue Remodeling Device

Phase 2 completed other

Facial Rhytides

CT.gov ↗
NCT00890682
SKY0402

Phase 3 completed small_molecule

Bunion

CT.gov ↗
NCT00890721
SKY0402

Phase 3 completed small_molecule

Hemorrhoid

CT.gov ↗
NCT01167140
Cryo-Touch II

Phase 3 completed other

Facial Wrinkles

CT.gov ↗
NCT01203644
SKY0402

Phase 2 completed small_molecule

Inguinal Hernia

CT.gov ↗
NCT01206595
SKY0402

Phase 2 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT01206608
SKY0402 + bupivacaine HCl

Phase 2 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT01291914
FX005

Phase 2 completed small_molecule

Osteoarthritis, Knee

CT.gov ↗
NCT01349140
SKY0402

Phase 1 completed small_molecule

Healthy Volunteers

CT.gov ↗
NCT01379365
Cryo-Touch III

Phase 3 completed other

Facial Wrinkles

CT.gov ↗
NCT01447342
Cryo-Touch II

Phase 3 completed other

Facial Wrinkles

CT.gov ↗
NCT01487161
FX006

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT01487200
FX006 10 mg

Phase 2 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT01507220
morphine sulfate

Approved terminated small_molecule

Bowel Obstruction

CT.gov ↗
NCT01507233
IV morphine sulfate

Approved terminated small_molecule

Bowel Obstruction

CT.gov ↗
NCT01507246
IV morphine sulfate

Approved terminated small_molecule

Bowel Obstruction

CT.gov ↗
NCT01509638
Group 1 Standard of Care

Approved completed small_molecule

Retraction of Colostomy

CT.gov ↗
NCT01509807
IV morphine sulfate or Sponsor-approved equivalent

Approved completed small_molecule

Retraction of Colostomy

CT.gov ↗
NCT01582477
EXPAREL 20 mL

Approved completed small_molecule

Postsurgical Pain

CT.gov ↗
NCT01582490
Instillation - EXPAREL

Approved completed small_molecule

Mammoplasty

CT.gov ↗
NCT01683071
Placebo

Phase 3 completed small_molecule

Postoperative Pain

CT.gov ↗
NCT01801124
EXPAREL

Approved completed small_molecule

Hernia

CT.gov ↗
NCT01802411
EXPAREL 266 mg

Phase 3 completed small_molecule

Posterolateral Thoracotomy

CT.gov ↗
NCT01919190
EXPAREL

Approved completed small_molecule

Pain

CT.gov ↗
NCT01919606
EXPAREL

Approved active small_molecule

Postoperative Pain

CT.gov ↗
NCT02003365
FX006 10 mg

Phase 2 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02058290
IV morphine sulfate or Sponsor-approved equivalent

Approved terminated small_molecule

Bowel Obstruction

CT.gov ↗
NCT02058303
Exparel Forearm block

Approved terminated small_molecule

Hand Injuries

CT.gov ↗
NCT02116972
FX006 32 mg

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02128646
EXPAREL

Approved completed small_molecule

Pain

CT.gov ↗
NCT02142829
EXPAREL

Approved completed small_molecule

Obesity

CT.gov ↗
NCT02199574
EXPAREL

Approved completed small_molecule

Pain

CT.gov ↗
NCT02210247
EXPAREL

Phase 1 completed small_molecule

Healthy Volunteers

CT.gov ↗
NCT02255500
Bupivacaine FNB

Approved completed small_molecule

Pain

CT.gov ↗
NCT02284386
Bupivacaine SNB

Approved completed small_molecule

Pain

CT.gov ↗
NCT02353754
Intrathecal morphine injection

Approved terminated small_molecule

Pain

CT.gov ↗
NCT02357459
FX006

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02468583
FX006 32 mg

Phase 2 terminated small_molecule

Post-traumatic Osteoarthritis of the Knee

CT.gov ↗
NCT02517905
Bupivacaine liposome

Phase 3 completed small_molecule

Dental Pain

CT.gov ↗
NCT02554357
Exparel block in arthroscopic shoulder surgery

Unknown completed small_molecule

Injury of Shoulder Region

CT.gov ↗
NCT02586077
Exparel

Approved completed small_molecule

Ankle Arthrodesis

CT.gov ↗
NCT02637323
FX006 32 mg

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02713178
bupivacaine liposome injectable suspension

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT02713230
bupivacaine liposome injectable suspension

Phase 3 completed small_molecule

Pain

CT.gov ↗
NCT02713490
EXPAREL

Approved completed small_molecule

Pain

CT.gov ↗
NCT02740114
Bupivacaine

Phase 3 terminated small_molecule

Malignant Neoplasms of Female Genital Organs

CT.gov ↗
NCT02762370
FX006 32 mg

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT02787226
Liposomal Bupivacaine Infiltration

Approved terminated small_molecule

Postoperative Pain

CT.gov ↗
NCT02922582
DepoTXA

Phase 2 terminated small_molecule

Total Knee Arthroplasty

CT.gov ↗
NCT02985762
EXPAREL

Phase 1 completed small_molecule

Spinal Fusion

CT.gov ↗
NCT03015961
EXPAREL and bupivacaine HCl

Approved terminated small_molecule

Postoperative Pain Management

CT.gov ↗
NCT03046446
FX006 32 mg

Phase 3 completed small_molecule

Osteoarthritis of the Knee

CT.gov ↗
NCT03106519
Liposome bupivacaine + bupivacaine

Phase 2 completed small_molecule

Dupuytren's Contracture of the Hand (Viking's Disease)

CT.gov ↗
NCT03106545
Liposome bupivacaine

Phase 2 completed small_molecule

Hallux Valgus (Bunions)

CT.gov ↗
NCT03149887
Liposomal bupivacaine

Approved completed small_molecule

Rotator Cuff Tear

CT.gov ↗
NCT03176459
Exparel + Bupivacaine

Approved completed small_molecule

C-Section

CT.gov ↗
NCT03270514
Exparel Injectable Product

Phase 3 completed small_molecule

Coronary Artery Disease

CT.gov ↗
NCT03290196
EXPAREL 1.3 % in 20 ML Injection

Approved terminated small_molecule

Rotator Cuff Tear

CT.gov ↗
NCT03378076
FX006 32 mg

Phase 2 completed small_molecule

Bilateral Knee Osteoarthritis

CT.gov ↗
NCT03382262
FX006 32 mg

Phase 2 completed small_molecule

Osteoarthritis of the Shoulder

CT.gov ↗
NCT03428984
Exparel

Phase 3 completed small_molecule

Postoperative Pain Management

CT.gov ↗
NCT03485014
Exparel

Phase 3 completed small_molecule

Postoperative Pain Management

CT.gov ↗
NCT03529942
FX006 32 mg

Phase 3 completed small_molecule

Osteoarthritis, Knee

CT.gov ↗
NCT03541941
Exparel

Approved completed small_molecule

Analgesia, Postoperative

CT.gov ↗
NCT03682302
Exparel

Phase 3 completed small_molecule

Postoperative Pain Management

CT.gov ↗
NCT03738696
Exparel

Approved completed small_molecule

Rotator Cuff Injury

CT.gov ↗
NCT03739021
Exparel

Phase 3 active small_molecule

Chronic Shoulder Pain

CT.gov ↗
NCT03793010
FX006

Phase 3 terminated small_molecule

Osteoarthritis, Hip

CT.gov ↗
NCT03802864
Liposomal Bupivacaine

Approved completed small_molecule

Male Infertility

CT.gov ↗
NCT03827291
Exparel

Approved completed small_molecule

Laparotomy

CT.gov ↗
NCT03853694
50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

Approved completed small_molecule

Elective Cesarean Section

CT.gov ↗
NCT03907033
Liposomal bupivacaine

Approved terminated small_molecule

Vaginal Hysterectomy

CT.gov ↗
NCT03927911
EXPAREL and Bupivacaine

Approved terminated small_molecule

Postoperative Pain Management

CT.gov ↗
NCT03954639
EXPAREL 13.3Mg/mL Suspension for Injection

Phase 3 terminated small_molecule

Bunion

CT.gov ↗
NCT03955458
EXPAREL

Approved terminated small_molecule

Hip Fractures

CT.gov ↗
NCT03975283
Exparel 266 MG Per 20 ML Injection

Approved active small_molecule

Post Operative Pain

CT.gov ↗
NCT04002089
Exparel Injectable Product

Phase 1 completed small_molecule

Bunion

CT.gov ↗
NCT04065074
FX006 32 mg

Phase 2 completed small_molecule

Osteoarthritis, Hip

CT.gov ↗
NCT04117074
Liposomal bupivacaine

Phase 3 completed small_molecule

Surgery

CT.gov ↗
NCT04119687
FX201

Phase 1 active mab

Osteoarthritis, Knee

CT.gov ↗
NCT04160091
FX006

Phase 2 terminated small_molecule

Osteoarthritis of the Shoulder

CT.gov ↗
NCT04173611
EXPAREL

Phase 1 terminated small_molecule

Healthy

CT.gov ↗
NCT04182672
FX006

Phase 2 completed small_molecule

Trochanteric Bursitis

CT.gov ↗
NCT04261049
Triamcinolone Acetonide Extended-Release Injectable Suspension

Phase 1 completed small_molecule

Osteoarthritis, Knee

CT.gov ↗
NCT04278846
Depofoam bupivacaine

Approved completed small_molecule

Pain, Postoperative

CT.gov ↗
NCT04293809
Exparel Injectable Product

Phase 1 completed small_molecule

Breast Augmentation

CT.gov ↗
NCT04504812
Duloxetine

Phase 3 completed small_molecule

Knee Osteoarthritis

CT.gov ↗
NCT04518462
Exparel

Phase 3 completed small_molecule

Lower Extremity Surgery

CT.gov ↗
NCT04826328
FX301

Phase 1 completed small_molecule

Pain, Postoperative

CT.gov ↗
NCT05139030
bupivacaine liposome injectable suspension

Phase 3 completed small_molecule

Knee Osteoarthritis

CT.gov ↗
NCT05157841
Bupivacaine liposome injectable suspension 266 mg

Phase 3 completed small_molecule

Bunionectomy

CT.gov ↗
NCT05171179
Exparel

Phase 3 completed small_molecule

Mammaplasty

CT.gov ↗
NCT05456490
Liposomal Bupivacaine 13.3

Phase 1 completed small_molecule

Healthy

CT.gov ↗
NCT05730920
Methadone

Approved completed small_molecule

Adolescent Idiopathic Scoliosis

CT.gov ↗
NCT06077422
bupivacaine liposome injectable suspension

Phase 3 active small_molecule

Pain, Postoperative

CT.gov ↗
NCT06269705
ZILRETTA

Phase 3 active small_molecule

Glenohumeral Osteoarthritis

CT.gov ↗
NCT06271265
EXPAREL

Approved active small_molecule

Postoperative Pain

CT.gov ↗
NCT06350981
Exparel

Phase 3 active small_molecule

Back Pain

CT.gov ↗
NCT06884865
Enekinragene Inzadenovec (PCRX-201)

Phase 2 active mab

Osteoarthritis (OA) of the Knee

CT.gov ↗
NCT06977568
Zilretta

Phase 2 terminated small_molecule

Osteoarthritis of Hip

CT.gov ↗
NCT06995352
Popliteal nerve block including liposomal bupivacaine

Approved active small_molecule

Moderate-to-severely Painful Ankle Surgery

CT.gov ↗
NCT07212114
EXPAREL

Phase 3 active small_molecule

Total Ankle Arthroplasty

CT.gov ↗
NCT07584915
Bupivacaine liposome injectable suspension (IPSA block)

Approved active small_molecule

Total Knee Arthroplasty

CT.gov ↗